Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort

Journal of Neurology

Volumn 256, Issue 10, 2009, Pages 1671-1680

  Linder, Jan ^a   Birgander, Richard ^a   Olsson, Ingegerd ^a   Riklund, Katrine ^a   Larsson, Ann Katrine ^a   Edström, Mona ^a   Stenlund, Hans ^a   Forsgren, Lars ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diagnosis; MRI; Parkinson's disease; Parkinsonism

Indexed keywords

ADULT; AGED; ARTICLE; BODY EQUILIBRIUM; CEREBELLUM CORTEX; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SUPERIOR CEREBELLAR PEDUNCLE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; CEREBELLUM; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70349651971     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5177-4     Document Type: Article

References (31)

1. HJ Acharya TP Bouchard DJ Emery RM Camicioli 2007 Axial signs and magnetic resonance imaging correlates in Parkinson's disease Can J Neurol Sci 34 56 61 17352348
2. G Alves JP Larsen M Emre T Wentzel-Larsen D Aarsland 2006 Changes in motor subtype and risk for incident dementia in Parkinson's disease Mov Disord 21 1123 1130 10.1002/mds.20897 16637023 10.1002/mds.20897 (Pubitemid 44336596)
3. TS Benamer J Patterson DG Grosset J Booij K de Bruin E van Royen JD Speelman MH Horstink HJ Sips RA Dierckx J Versijpt D Decoo C Van Der Linden DM Hadley M Doder AJ Lees DC Costa S Gacinovic WH Oertel O Pogarell H Hoeffken K Joseph K Tatsch J Schwarz V Ries 2000 Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group Mov Disord 15 503 510 10.1002/1531-8257(200005)15: 3<503::AID-MDS1013>3.0.CO;2-V 10830416 10.1002/1531-8257(200005)15: 3<503::AID-MDS1013>3.0.CO;2-V 1:STN:280:DC%2BD3cvnsVSntw%3D%3D (Pubitemid 30333223)
4. K Bhattacharya D Saadia B Eisenkraft M Yahr W Olanow B Drayer H Kaufmann 2002 Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm Arch Neurol 59 835 842 10.1001/archneur.59.5.835 12020268 10.1001/archneur.59.5.835
5. EJ Burton IG McKeith DJ Burn ED Williams OB JT 2004 Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls Brain 127 791 800 10.1093/brain/awh088 14749292 10.1093/brain/awh088 (Pubitemid 38478524)
6. LM de Lau PC Giesbergen MC de Rijk A Hofman PJ Koudstaal MM Breteler 2004 Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study Neurology 63 1240 1244 15477545
7. WR Gibb AJ Lees 1988 The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 51 745 752 10.1136/jnnp.51.6.745 2841426 10.1136/jnnp.51.6.745 1:STN:280: DyaL1czgtVSqsg%3D%3D
8. S Gilman PA Low N Quinn A Albanese Y Ben-Shlomo CJ Fowler H Kaufmann T Klockgether AE Lang PL Lantos I Litvan CJ Mathias E Oliver D Robertson I Schatz GK Wenning 1999 Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 94 98 10.1016/S0022-510X(98)00304-9 10223419 10.1016/S0022-510X(98)00304-9 1:STN:280:DyaK1M3jsl2gsg%3D%3D (Pubitemid 29155424)
9. HJ Gundersen EB Jensen 1987 The efficiency of systematic sampling in stereology and its prediction J Microsc 147 229 263 3430576 1:STN:280: DyaL1c7hvVyltA%3D%3D
10. M Hutchinson U Raff 2008 Detection of Parkinson's disease by MRI: spin-lattice distribution imaging Mov Disord 23 1991 1997 10.1002/mds.22210 18759364 10.1002/mds.22210
11. N Kato K Arai T Hattori 2003 Study of the rostral midbrain atrophy in progressive supranuclear palsy J Neurol Sci 210 57 60 10.1016/S0022-510X(03) 00014-5 12736089 10.1016/S0022-510X(03)00014-5 (Pubitemid 36539405)
12. R Katzenschlager A Cardozo MR Avila Cobo E Tolosa AJ Lees 2003 Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders Mov Disord 18 1123 1131 10.1002/mds.10523 14534915 10.1002/mds.10523 (Pubitemid 37336935)
13. EA Lee HI Cho SS Kim WY Lee 2004 Comparison of magnetic resonance imaging in subtypes of multiple system atrophy Parkinsonism Relat Disord 10 363 368 10.1016/j.parkreldis.2004.04.008 15261878 10.1016/j.parkreldis.2004.04.008 (Pubitemid 38942792)
14. I Litvan Y Agid D Calne G Campbell B Dubois RC Duvoisin CG Goetz LI Golbe J Grafman JH Growdon M Hallett J Jankovic NP Quinn E Tolosa DS Zee 1996 Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1 9 8710059 1:STN:280:DyaK283ptFSjtA%3D%3D
15. I Litvan KP Bhatia DJ Burn CG Goetz AE Lang I McKeith N Quinn KD Sethi C Shults GK Wenning 2003 Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders Mov Disord 18 467 486 10.1002/mds.10459 12722160 10.1002/mds.10459 (Pubitemid 36656531)
16. VL Marshall J Patterson DM Hadley KA Grosset DG Grosset 2006 Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging Nucl Med Commun 27 933 937 10.1097/01.mnm.0000243374.11260.5b 17088677 10.1097/01.mnm.0000243374.11260.5b (Pubitemid 44706887)
17. L Minati M Grisoli F Carella T De Simone MG Bruzzone M Savoiardo 2007 Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging AJNR Am J Neuroradiol 28 309 313 17297002 1:STN:280:DC%2BD2s%2FpvVSqsA%3D%3D
18. T Ngandu E von Strauss EL Helkala B Winblad A Nissinen J Tuomilehto H Soininen M Kivipelto 2007 Education and dementia: what lies behind the association? Neurology 69 1442 1450 10.1212/01.wnl.0000277456.29440.16 17909157 10.1212/01.wnl.0000277456.29440.16 1:STN:280:DC%2BD2srovVSrsQ%3D%3D (Pubitemid 47511466)
19. G Nicoletti R Lodi F Condino C Tonon F Fera E Malucelli D Manners M Zappia L Morgante P Barone B Barbiroli A Quattrone 2006 Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy Brain 129 2679 2687 10.1093/brain/awl166 16815875 10.1093/brain/awl166 (Pubitemid 44522101)
20. DC Paviour SL Price M Jahanshahi AJ Lees NC Fox 2006 Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations Mov Disord 21 989 996 10.1002/mds.20877 16602104 10.1002/mds.20877 (Pubitemid 44184601)
21. DC Paviour SL Price JM Stevens AJ Lees NC Fox 2005 Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy Neurology 64 675 679 15728291 1:STN:280:DC%2BD2M%2FpvVyjuw%3D%3D
22. S Price D Paviour R Scahill J Stevens M Rossor A Lees N Fox 2004 Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease Neuroimage 23 663 669 10.1016/j.neuroimage.2004.06.013 15488416 10.1016/j.neuroimage.2004.06.013 (Pubitemid 39370617)
23. A Righini A Antonini R De Notaris E Bianchini N Meucci G Sacilotto M Canesi D De Gaspari F Triulzi G Pezzoli 2004 MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease AJNR Am J Neuroradiol 25 927 932 15205125
24. M Savoiardo 2003 Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging Neurol Sci 24 Suppl 1 S35 S37 10.1007/s100720300036 12774211 10.1007/s100720300036 (Pubitemid 36621545)
25. JB Schulz M Skalej D Wedekind AR Luft M Abele K Voigt J Dichgans T Klockgether 1999 Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy Ann Neurol 45 65 74 10.1002/1531-8249(199901)45:1<65::AID- ART12>3.0.CO;2-1 9894879 10.1002/1531-8249(199901)45:1<65::AID-ART12>3. 0.CO;2-1 1:STN:280:DyaK1M7htVWksg%3D%3D (Pubitemid 29036434)
26. K Seppi MF Schocke 2005 An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism Curr Opin Neurol 18 370 375 10.1097/01.wco.0000173141.74137.63 16003111 10.1097/01.wco.0000173141.74137.63
27. K Seppi MF Schocke GK Wenning W Poewe 2005 How to diagnose MSA early: the role of magnetic resonance imaging J Neural Transm 112 1625 1634 10.1007/s00702-005-0332-2 15997415 10.1007/s00702-005-0332-2 1:STN:280:DC%2BD2MngsVGquw%3D%3D (Pubitemid 41598968)
28. KS Taylor CE Counsell CE Harris JC Gordon WC Smith 2006 Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results Mov Disord 21 976 982 10.1002/mds.20866 16570298 10.1002/mds.20866 (Pubitemid 44184599)
29. SK Van Den Eeden CM Tanner AL Bernstein RD Fross A Leimpeter DA Bloch LM Nelson 2003 Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity Am J Epidemiol 157 1015 1022 10.1093/aje/kwg068 10.1093/aje/kwg068
30. H Watanabe H Fukatsu M Katsuno M Sugiura K Hamada Y Okada M Hirayama T Ishigaki G Sobue 2004 Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker J Neurol Neurosurg Psychiatry 75 103 109 14707317 1:STN:280: DC%2BD2c%2FhtVahtQ%3D%3D
31. F Yekhlef G Ballan F Macia O Delmer C Sourgen F Tison 2003 Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD J Neural Transm 110 151 169 10.1007/s00702-002-0785-5 12589575 10.1007/s00702-002-0785-5 1:STN:280:DC%2BD3s%2FnvVWktg%3D%3D (Pubitemid 36216498)